GDF15型
萧条(经济学)
重性抑郁障碍
内科学
胰岛素抵抗
生物标志物
队列
心理学
胰岛素样生长因子
内分泌学
医学
胰岛素
肿瘤科
临床心理学
抑郁症状
糖尿病
联想(心理学)
队列研究
病例对照研究
心理健康
2型糖尿病
混淆
年轻人
生长因子
精神科
作者
Mareike Aichholzer,Carmen Schiweck,Aicha Bouzouina,Carmen Uckermark,Sarah Mackert,A. Balliet,Florian Erhardt,J. Freiling,Viet Hoang Nguyen,Lara Bruder,Miriam Grossmann,Silke Matura,Jonathan Repple,Christine Reif-Leonhard,Harry Pantazopoulos,Klaus Lieb,Jan Engelmann,Martin A. Picard,Yuri Milaneschi,Nils C. Gassen
标识
DOI:10.1176/appi.ajp.20251275
摘要
OBJECTIVE: Major depressive disorder (MDD) is linked to insulin resistance, which is associated with increased risk, chronicity, and poor treatment response in depression. Growth differentiation factor 15 (GDF15), a stress-induced cytokine linking peripheral to central energy metabolism, may mediate this link, but its role in MDD is unclear. The authors assessed associations of MDD and insulin resistance with GDF15; links between GDF15, symptoms, and stress; and whether baseline GDF15 levels predict symptom persistence. METHODS: In this preregistered secondary analysis, 190 participants with MDD and 183 control participants provided blood, underwent interviews, and completed questionnaires. GDF15 values were log-transformed and analyzed with linear models. The association between GDF15 and depression severity was validated in an independent cohort of medication-free MDD patients (N=168). RESULTS: Both MDD diagnosis and insulin resistance were significantly associated with elevated GDF15 (adjusted for age and sex). Across all participants, elevated GDF15 was significantly associated with greater depressive severity, childhood trauma, and perceived stress. In stratified analyses, the association with depression severity and perceived stress was significant only in healthy control subjects. In MDD patients, baseline GDF15 was associated with persistence of symptoms across time. In the second independent sample of medication-free MDD patients, depression severity was significantly associated with GDF15. CONCLUSIONS: GDF15 is elevated in MDD and insulin resistance, indicating convergent stress-energy pathway activation, and in MDD higher GDF15 predicted symptom persistence. These findings position GDF15 as a mechanistic biomarker at the interface of psychiatric and metabolic health and reinforce the need for integrated care of metabolic and mental health.
科研通智能强力驱动
Strongly Powered by AbleSci AI